SAM
GNCA
Shamrock Asset Management’s Genocea Biosciences, Inc. GNCA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $0 | Hold |
63
| – | – | ﹤0.01% | 273 |
|
|
2019
Q2 | $0 | Sell |
63
-437
| -87% | – | ﹤0.01% | 271 |
|
|
2019
Q1 | $0 | Hold |
500
| – | – | ﹤0.01% | 265 |
|
|
2018
Q4 | $0 | Hold |
500
| – | – | ﹤0.01% | 270 |
|
|
2018
Q3 | $0 | Hold |
500
| – | – | ﹤0.01% | 296 |
|
|
2018
Q2 | $0 | Hold |
500
| – | – | ﹤0.01% | 312 |
|
|
2018
Q1 | $0 | Hold |
500
| – | – | ﹤0.01% | 319 |
|
|
2017
Q4 | $1K | Hold |
500
| – | – | ﹤0.01% | 278 |
|
|
2017
Q3 | $1K | Sell |
500
-500
| -50% | -$1K | ﹤0.01% | 269 |
|
|
2017
Q2 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 261 |
|
|
2017
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 245 |
|
|
2016
Q4 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 243 |
|
|
2016
Q3 | $5K | Buy |
1,000
+500
| +100% | +$2.5K | ﹤0.01% | 238 |
|
|
2016
Q2 | $2K | Buy |
+500
| New | +$2K | ﹤0.01% | 252 |
|